 |
FTV1+GDP-fucose |
|---|---|
| Trade Name | |
| Orphan Indication | To improve homing to bone (treatment of myeloablation) in patients receiving hematopoietic stem cell transplantation |
| USA Market Approval | USA |
| USA Designation Date | 2011-03-18 00:00:00 |
| Sponsor | America Stem Cell, Inc.;11014 Bar X Trail;Helotes, Texas, 78023 |
